Thomas E. Starzl

78.4k total citations · 13 hit papers
1.3k papers, 56.9k citations indexed

About

Thomas E. Starzl is a scholar working on Surgery, Transplantation and Hepatology. According to data from OpenAlex, Thomas E. Starzl has authored 1.3k papers receiving a total of 56.9k indexed citations (citations by other indexed papers that have themselves been cited), including 811 papers in Surgery, 409 papers in Transplantation and 389 papers in Hepatology. Recurrent topics in Thomas E. Starzl's work include Organ Transplantation Techniques and Outcomes (615 papers), Renal Transplantation Outcomes and Treatments (366 papers) and Liver Disease and Transplantation (276 papers). Thomas E. Starzl is often cited by papers focused on Organ Transplantation Techniques and Outcomes (615 papers), Renal Transplantation Outcomes and Treatments (366 papers) and Liver Disease and Transplantation (276 papers). Thomas E. Starzl collaborates with scholars based in United States, Italy and United Kingdom. Thomas E. Starzl's co-authors include Shunzaburo Iwatsuki, John J. Fung, Andreas G. Tzakis, Satoru Todo, Anthony J. Demetris, Byers W. Shaw, L Makowka, Robert D. Gordon, Noriko Murase and David H. Van Thiel and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas E. Starzl

1.2k papers receiving 53.2k citations

Hit Papers

REVERSIBILITY OF LYMPHOMA... 1968 2026 1987 2006 1984 1982 1995 1988 1985 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas E. Starzl 32.3k 22.4k 13.4k 12.7k 6.7k 1.3k 56.9k
John J. Fung 21.1k 0.7× 14.7k 0.7× 12.0k 0.9× 10.6k 0.8× 5.4k 0.8× 1.2k 44.3k
Ronald W. Busuttil 19.8k 0.6× 18.3k 0.8× 3.8k 0.3× 10.9k 0.9× 2.6k 0.4× 757 37.7k
Andreas G. Tzakis 14.2k 0.4× 8.8k 0.4× 7.6k 0.6× 5.3k 0.4× 1.7k 0.2× 656 23.4k
Shinji Üemoto 15.3k 0.5× 13.9k 0.6× 2.5k 0.2× 6.7k 0.5× 4.5k 0.7× 954 26.7k
Michael P. Manns 11.2k 0.3× 46.8k 2.1× 1.4k 0.1× 41.9k 3.3× 7.9k 1.2× 1.3k 76.8k
Russell H. Wiesner 16.2k 0.5× 24.0k 1.1× 3.5k 0.3× 18.0k 1.4× 2.0k 0.3× 332 32.8k
Pierre–Alain Clavien 18.3k 0.6× 13.1k 0.6× 1.2k 0.1× 6.4k 0.5× 5.6k 0.8× 480 28.0k
Michaël Abécassis 10.2k 0.3× 15.5k 0.7× 3.4k 0.3× 8.3k 0.6× 2.6k 0.4× 333 23.8k
David E. Kleiner 7.3k 0.2× 17.6k 0.8× 1.3k 0.1× 32.1k 2.5× 6.8k 1.0× 515 50.7k
Richard L. Simmons 7.6k 0.2× 1.6k 0.1× 3.0k 0.2× 6.3k 0.5× 4.1k 0.6× 592 32.6k

Countries citing papers authored by Thomas E. Starzl

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Starzl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Starzl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Starzl more than expected).

Fields of papers citing papers by Thomas E. Starzl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Starzl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Starzl. The network helps show where Thomas E. Starzl may publish in the future.

Co-authorship network of co-authors of Thomas E. Starzl

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Starzl. A scholar is included among the top collaborators of Thomas E. Starzl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Starzl. Thomas E. Starzl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Starzl, Thomas E., et al.. (2013). Fifty years later.. PubMed. 105–9. 1 indexed citations
2.
Starzl, Thomas E.. (2008). What does—and does not—spur innovation?. Cleveland Clinic Journal of Medicine. 75. 1 indexed citations
3.
Shapiro, Ron, Amit Basu, Henkie P. Tan, et al.. (2005). Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. Journal of the American College of Surgeons. 200(4). 505–515. 124 indexed citations
4.
Thai, Ngoc, Kareem Abu‐Elmagd, Geoffrey Bond, et al.. (2004). Pancreatic transplantation at the University of Pittsburgh.. PubMed. 205–14. 9 indexed citations
5.
Pham, Si M., Abdul S. Rao, Adriana Zeevi, et al.. (2000). A clinical trial combining donor bone marrow infusion and heart transplantation: Intermediate-term results. Journal of Thoracic and Cardiovascular Surgery. 119(4). 673–681. 29 indexed citations
6.
Fung, John J., et al.. (2000). 가족성 용종증 환자에서 시행한 췌장-소장 이식. Journal of the Korean Surgical Society. 58(6). 867–871. 3 indexed citations
7.
Shapiro, R, Mark L. Jordan, Velma P. Scantlebury, et al.. (1997). Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. Clinical Transplantation. 11(3). 237–242. 55 indexed citations
8.
Rugeles, Marı́a Teresa, Abdelouahab Aı̈touche, Adriana Zeevi, et al.. (1997). EVIDENCE FOR THE PRESENCE OF MULTILINEAGE CHIMERISM AND PROGENITORS OF DONOR DENDRITIC CELLS IN THE PERIPHERAL BLOOD OF BONE MARROW-AUGMENTED ORGAN TRANSPLANT RECIPIENTS1. Transplantation. 64(5). 735–741. 26 indexed citations
9.
Pham, Si M., Robert L. Kormos, Brack Hattler, et al.. (1996). A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: Intermediate-term results. Journal of Thoracic and Cardiovascular Surgery. 111(4). 764–772. 113 indexed citations
10.
Starzl, Thomas E.. (1995). Peter Brian Medawar: father of transplantation.. PubMed. 180(3). 332–6. 14 indexed citations
11.
Polimeno, Lorenzo, Alessandro Azzarone, Carmine Panella, et al.. (1995). Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells.. PubMed. 21(4). 1070–8. 55 indexed citations
12.
Thomson, Angus W. & Thomas E. Starzl. (1994). Immunosuppressive drugs : developments in anti-rejection therapy. 29 indexed citations
13.
Nakamura, Kenji, et al.. (1993). Sodium lactobionate sucrose solution for canine liver and kidney preservation.. PubMed. 25(1 Pt 2). 1618–9. 1 indexed citations
14.
Starzl, Thomas E.. (1993). Chimerism after Whole Organ Transplant. Guthrie Journal. 62(2). 49–53. 1 indexed citations
15.
Francavilla, A., Thomas E. Starzl, Ken A. Porter, et al.. (1991). Screening for candidate hepatic growth factors by selective portal infusion after canine Eck’s fistula. Hepatology. 14(4). 665–670. 80 indexed citations
16.
Stieber, A, Giovanni Ambrosino, D. Kahn, et al.. (1988). An Unusual Complication of Choledochocholedochostomy in Orthotopic Liver Transplantation. Transplantation Proceedings. 20. 619. 21 indexed citations
17.
Starzl, Thomas E., T.R. Hakala, J. Thomas Rosenthal, S Iwatsuki, & B. W. Shaw. (1983). The Colorado-Pittsburgh Cadaveric Renal Transplantation Study with Cyclosporine. Transplantation Proceedings. 15. 2459. 30 indexed citations
18.
Putnam, Charles W. & Thomas E. Starzl. (1977). Simplified biopsy of the liver in dogs.. D-Scholarship@Pitt (University of Pittsburgh). 144(5). 759–759. 2 indexed citations
19.
Penn, Israel & Thomas E. Starzl. (1972). The Effect of Immunosuppression on Cancer. 7. 425. 13 indexed citations
20.
Barnes, Benjamin A., John B. Dossetor, David M. Hume, et al.. (1968). SIXTH REPORT OF THE HUMAN KIDNEY TRANSPLANT REGISTRY SPONSORED BY THE ADVISORY COMMITTEE OF THE HUMAN KIDNEY TRANSPLANT REGISTRY Members of the Committee and affiliations are listed below. Transplantation. 6(8). 944–956. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026